Search

Hims & Hers Health Inc

Open

BrancheKonsumgüter defensiv

32.07 4.09

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

30.24

Max

31.73

Schlüsselkennzahlen

By Trading Economics

Einkommen

-113M

-92M

Verkäufe

-9.7M

608M

KGV

Branchendurchschnitt

57.137

33.699

EPS

-0.19

Gewinnspanne

-15.148

Angestellte

2,442

EBITDA

-107M

-80M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

-3.05% downside

Dividenden

By Acuity

Nächstes Ergebnis

10. Aug. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

266M

7B

Vorheriger Eröffnungskurs

27.98

Vorheriger Schlusskurs

32.07

Nachrichtenstimmung

By Acuity

50%

50%

52 / 130 Ranking in Consumer defensive

Hims & Hers Health Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Aug. 2026, 23:41 UTC

News

Hims & Hers Health shares are higher in after-market trading, following positive growth insights despite facing a lawsuit from the Federal Trade Commission.

31. Juli 2026, 19:36 UTC

Social Media
News

Hims & Hers Health Inc is trading higher amid social media discussions about potential undervaluation, despite facing a lawsuit over user health data practices.

30. Juli 2026, 20:11 UTC

Hims & Hers Health Inc shares are higher today amid high trading volume. Broader economic data showed mixed signals, contributing to market volatility.

29. Juli 2026, 23:16 UTC

Social Media
News

Hims & Hers Health shares declined in after-market trading amid legal challenges from the FTC over alleged privacy violations and a securities fraud investigation.

28. Juli 2026, 23:41 UTC

Hims & Hers Health shares declined in after-market trading, remaining near the lower end of their one-month range amid broader market pressures from Asian tech losses.

27. Juli 2026, 20:03 UTC

News
Social Media

Hims & Hers Health shares rise amid FDA committee's endorsement of peptides, seen as a significant step toward market access for treatments.

24. Juli 2026, 23:16 UTC

Social Media

Hims & Hers Health Inc. shares rose after-hours following positive votes from an FDA/HHS panel on six peptides, with a final decision expected in up to 12 months.

23. Juli 2026, 23:26 UTC

News

Hims & Hers Health Inc shares are higher after an FDA advisory panel recommended easing restrictions on a popular peptide and Canaccord reiterated a Buy rating.

22. Juli 2026, 23:16 UTC

News

Hims & Hers Health shares declined to about $31.66 after mixed options sentiment, with calls outpacing puts amid lighter trading volume.

21. Juli 2026, 17:31 UTC

News

Hims & Hers Health Inc shares are declining amid an investigation into potential wrongdoing and concerns over FDA approval of key peptides.

20. Juli 2026, 18:37 UTC

News

Hims & Hers Health Inc. is trading higher amid broader market dynamics, despite earlier pulling back from a session high.

Peer-Vergleich

Kursveränderung

Hims & Hers Health Inc Prognose

Kursziel

By TipRanks

-3.05% Nachteil

12-Monats-Prognose

Durchschnitt 29.88 USD  -3.05%

Hoch 40 USD

Tief 21 USD

Basierend auf 13 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Hims & Hers Health Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

13 ratings

4

Buy

9

Halten

0

Sell

Stimmung

By Acuity

52 / 130 Ranking in Konsumgüter defensiv

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
help-icon Live chat